SLC39A9 and urinary bladder cancer: The analysis of TCGA database then revealed that the expression of SLC39A9 was considerably elevated in bladder cancers (vs. non-tumors), which was further associated with significantly worse disease-free survival (p = 0.003) or overall survival (p = 0.008) [76].